New heart pump could help High-Risk patients during angioplasty
NCT ID NCT07407816
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a temporary heart pump called the Supira System in 45 people with heart failure and severe coronary artery disease who need high-risk angioplasty. The pump is inserted through a leg artery to help the heart pump blood during and after the procedure. Researchers want to see if it is safe and works well enough to avoid the need for more advanced support like a balloon pump or ECMO.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Supira System (a temporary heart pump inserted through a leg artery)
What this could lead to
If successful, this could provide a new option to support the heart during and after high-risk angioplasty, potentially reducing complications in people with severe heart disease.
What could go wrong
This is a small, early feasibility study with only 45 participants, so results may not apply to everyone. The device is inserted through an artery, which carries risks like bleeding, infection, or damage to blood vessels or the heart.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Israeli-Georgian Medical Research Clinic HealthyCore 13g Tevdore-Mghvdeli Street Tbilisi Georgia
RECRUITINGTbilisi, Georgia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tbilisi Heart and Vascular Clinic
RECRUITINGTbilisi, K'alak'i T'bilisi, 0112, Georgia
Contact Phone: •••-•••-•••• Email: •••••@•••••